QR Kod

Discovering new CDK2 inhibitors by molecular docking and drug-likeness-based virtual screening for potential anticancer uses.

Worldwide, cancer ranks as the second most lethal disease. There are several potential anticancer therapeutic targets, but CDK2 stands out. Not many third-generation CDK2 inhibitors targeting the kinase domain have made it to market yet, but there are plenty of first- and second-generation inhibitor...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Mahmoud Elkotamy, Mohamed Elgohary, Islam Elkelesh, Abdallah Hamdy
Materyal Türü: Artigo
Dil:Árabe
Baskı/Yayın Bilgisi: Egyptian Russian University 2024-10-01
Seri Bilgileri:ERU Research Journal
Konular:
Online Erişim:https://erurj.journals.ekb.eg/article_351728_db17859d93dee0c5684bb90496169c46.pdf
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!